SCYNEXIS
SCYX
£0.55
Share price
0.34%
Change (1 day)
-67.34%
Change (1 year)
Categories
SCYNEXIS (SCYX) - P/B ratio
P/B ratio as of July 2025 : 0.5657
According to SCYNEXIS's latest financial reports the company has a price-to-book ratio of 10.8693.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
SCYNEXIS - P/B ratio (from 2014 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 0.6884 | -39.47% |
| 2023-12-31 | 1.14 | -92.78% |
| 2022-12-31 | 15.8 | 345.01% |
| 2021-12-31 | 3.54 | -45.36% |
| 2020-12-31 | 6.48 | -5.72% |
| 2019-12-31 | 6.87 | 828.92% |
| 2018-12-31 | 0.7401 | -76.09% |
| 2017-12-31 | 3.09 | 40.8% |
| 2016-12-31 | 2.20 | 6.77% |
| 2015-12-31 | 2.06 | -18.99% |
| 2014-12-31 | 2.54 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | 0.2555 | -54.83% | 🇮🇱 Israel |
 KemPharm KMPH | 2.34 | 312.99% | 🇺🇸 USA |
 Catalent CTLT | 3.25 | 475.05% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 3.19 | 464.64% | 🇺🇸 USA |